Vimarsana
Biggest News Aggregation in the World

Page 35 - B Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Cell Today - Breaking & Trending Today

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants - Vimarsana News

Cross-recognition of SARS-CoV-2 vaccine-elicited T cell responses among different variants

In a new study, researchers evaluated SARS-CoV-2 vaccination-induced T cell responses cross-recognition among the early and novel SARS-CoV-2 variants.

Know everything about BENTA, the rare disease detected in a 7-month-old Bengaluru baby - Vimarsana News

Know everything about BENTA, the rare disease detected in a 7-month-old Bengaluru baby

Know everything about BENTA, the rare disease detected in a 7-month-old Bengaluru baby - Vijayadra's is first BENTA case that has been identified at an early stage in terms of age & severity. He can be saved by a blood stem cell transplant

Immune responses in Omicron breakthrough COVID-19 - Vimarsana News

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants - Vimarsana News

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

Moffitt experts provide insight on the role of B cell immunity in endometrial cancer - Vimarsana News

Moffitt experts provide insight on the role of B cell immunity in endometrial cancer

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells.